Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial
Branch-Elliman, Westyn, Ferguson, Ryan, Doros, Gheorghe, Woods, Patricia, Leatherman, Sarah, Strymish, Judith, Datta, Rupak, Goswami, Rekha, Jankowich, Matthew D, Shah, Nishant R, Taylor, Thomas H, Page, Sarah T, Schiller, Sara J, Shannon, Colleen, Hau, Cynthia, Flynn, Maura, Holmberg, Erika, Visnaw, Karen, Dhond, Rupali, Brophy, Mary, Monach, Paul A
Published in PloS one (25.02.2022)
Published in PloS one (25.02.2022)
Get full text
Journal Article
517. Subcutaneous Sarilumab for the Treatment of Hospitalized patients with Moderate to Severe COVID19 Disease: A Pragmatic, Embedded, Multi-Center Randomized Clinical Trial
Branch-Elliman, Westyn, Ferguson, Ryan, Doros, Gheorghe, Woods, Patricia, Leatherman, Sarah, Strymish, Judith, Datta, Rupak, Goswami, Rekha, Jankowich, Matthew, Shah, Nishant, Taylor, Thomas H, Page, Sarah T, Schiller, Sara, Shannon, Colleen, Hau, Cynthia, Flynn, Maura, Holmberg, Erika, Visnaw, Karen, Dhond, Rupali, Brophy, Mary, Monach, Paul
Published in Open forum infectious diseases (04.12.2021)
Published in Open forum infectious diseases (04.12.2021)
Get full text
Journal Article